Share ownership cbdMD, Inc.

YCBD

US12482W3097

Pharmaceuticals

Market Closed - Nyse Other stock markets 04:00:00 2025-01-13 pm EST			5-day change	1st Jan Change
0.4875 ^USD	-13.41%		-15.58%	+30.00%

Dec. 23	CbdMD, Inc. Appoints T. Ronan Kennedy to Its Board of Directors	CI
Dec. 18	CbdMD, Inc., Q4 2024 Earnings Call, Dec 18, 2024

Share class: cbdMD, Inc.

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	5,539,124	3,749,211 ( 67.69 %)	0	67.69 %
Stock B	0	5,000,000	0	0

Major shareholders: cbdMD, Inc.

Name	Equities	%	Valuation
Raymond Coffman 6.999 %	387,695	6.999 %	145 386 $
Crc Investment Fund LP 2.530 %	140,114	2.530 %	52 543 $
Connective Capital Management LLC 1.611 %	89,215	1.611 %	33 456 $
William Raines 1.521 %	84,256	1.521 %	31 596 $
Two Sigma Securities LLC 0.3984 %	22,066	0.3984 %	8 275 $
Vanguard Group, Inc. (Subfiler) 0.2355 %	13,042	0.2355 %	4 891 $
Geode Capital Management LLC 0.2021 %	11,195	0.2021 %	4 198 $
Scott Stephen 0.1830 %	10,138	0.1830 %	3 802 $
Bakari Sellers 0.1704 %	9,438	0.1704 %	3 539 $
BlackRock Institutional Trust Co. NA 0.1608 %	8,905	0.1608 %	3 339 $
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Name	Equities	%	Valuation
Chapin Davis, Inc. 1.600 %	80,000	1.600 %	62 400 $
CSS LLC 1.488 %	74,398	1.488 %	58 030 $
Thomas Ronan Kennedy 0.8353 %	41,765	0.8353 %	32 577 $
Alesco Advisors LLC 0.8353 %	41,765	0.8353 %	32 577 $
Commonwealth Equity Services LLC 0.2000 %	10,000	0.2000 %	7 800 $
Barclays Bank Plc 0.1000 %	5,000	0.1000 %	3 900 $
UBS Securities LLC 0.0751 %	3,756	0.0751 %	2 930 $
Morgan Stanley Smith Barney LLC 0.0154 %	768	0.0154 %	599 $

Breakdown by shareholder type

Individuals	9.03%
Other	2.93%
Institutional	2.23%
Unknown	85.81%

Based on 1000 largest holdings

Geographical origin of shareholders

Individuals	9.03%
United States	5.16%

Based on 1000 largest holdings

cbdMD, Inc. produces and distributes cannabidiol (CBD) products. The Company owns and operates CBD brands cbdMD, Paw CBD, and functional mushroom brand ATRx Labs. Its cbdMD brand of products includes a range of every day and functional CBD products, including tinctures; gummies; topicals; capsules; drink mixes; and sleep, focus and calming aids. Its Paw CBD brand of products includes a line of veterinarian-formulated products, including tinctures, chews, topicals products in varying strengths and formulas. Its ATRx brand was developed using the power of functional mushrooms to provide consumers with a complementary natural ingredient solution for immunity, focus, digestive health, cognitive, and mood benefits. cbdMD, Paw CBD, and ATRx products are distributed through its e-commerce Websites, third party e-commerce sites, select distributors, and marketing partners, as well as a variety of brick-and-mortar retailers.

Employees

Sector

Pharmaceuticals

Calendar

2025-02-11 - Q1 2025 Earnings Release (Projected)

More about the company